Plunkett’s Industry Almanacs in Printed and eBook Formats

Key Findings:

A complete market research report, including forecasts and market estimates, technologies analysis and developments at innovative firms within the Biotech, Pharmaceuticals & Genetics Industry.Gain vital insights that can help shape strategy for business development, product development and investments.

Key Features:

• Business trends analysis
• In-depth industry overview
• Technology trends analysis
• Forecasts
• Spending, investment, and consumption discussions
• In-depth industry statistics and metrics
• Industry employment numbers
  
  

Additional Key Features Include:

Industry Glossary

Industry Contacts list, including Professional Societies and Industry Associations

Profiles of industry-leading companies

• U.S. and Global Firms
• Publicly held, Private and Subsidiaries
• Executive Contacts
• Revenues

• For Public Companies: Detailed Financial Summaries

• Statistical Tables
  
  

Key Questions Answered Include:

• How is the industry evolving?
• How is the industry being shaped by new technologies?
• How is demand growing in emerging markets and mature economies?
• What is the size of the market now and in the future?
• What are the financial results of the leading companies?
• What are the names and titles of top executives?
• What are the top companies and what are their revenues?
  
  

This feature-rich report covers competitive intelligence, market research and business analysis—everything you need to know about the Biotech, Pharmaceuticals & Genetics Industry.

Plunkett Research Provides Unique Analysis of the Following Major Trends Affecting the Biotech, Pharmaceuticals & Genetics Industry

1. Major Trends Affecting the Biotech, Pharmaceuticals & Genetics Industry

2. The State of the Biotechnology Industry Today

3. A Short History of Biotechnology

4. Fast Track Drugs Come to Market in the U.S. with FDA Cooperation

5. Ethanol Production Is Massive for Fuel Additives

6. Cellulosic Ethanol Makes Slow Commercial Progress

7. Major Drug Companies Acquire or Partner With Smaller Biotech Firms

8. Pharmaceutical R&D Improves with Artificial Intelligence (AI)

9. Nations Compete Fiercely in Biotech Development

10. Patients’ Genetic Profiles Plummet in Price as DNA Sequencing Technologies Advance

11. Gene Therapies Target Defective Genes/CRISPR Advances DNA Editing

12. Vaccines & Viruses as Therapies/mRNA Shows Great Promise

13. Massive R&D Investment Required for Development and Approval of New Drugs/Drug Prices Soar

14. Generic Drugs Have Biggest Market Share by Unit Volume, but not by Total Revenues

15. America Pays Higher Prices for Drugs Than Other Nations/U.S. Government Launches Drug Price Negotiation and Control Powers for Medicare

16. Biotech and Orphan Drugs Create New Revenues for Drug Firms

17. Revolutionary New Drugs (Zepbound, Wegovy and Ozempic) Treat Obesity, Diabetes and Addiction/Show Promise for Treating Many Other Diseases

18. Biosimilars (Generic Biotech Drugs) Receive FDA Guidelines for Accelerated Approval/Competition Will Be Fierce

19. Market for CBD Remains Steady

20. Stem Cells and 3-D Printing—A New Era of Tissue Replacement Takes Shape

21. Genetically Modified (GM) Seeds and Crops Planted in Dozens of Nations/Agribio R&D Investment Is High

22. Genetically Modified (GM) Foods Prompt Controversy, Labeling and Legislation

23. Plant-Based Meat Substitutes Developed

24. Selective Plant Breeding, Mutagenesis and Gene-Editing, Including CRISPR, as Alternatives to GM Seeds

25. Immunotherapy, ADCs and CAR-T Create Exciting New Approach to Fighting Cancers

26. Technology Discussion—Genes and DNA

27. Technology Discussion—Proteins and Proteomics

28. Technology Discussion—DNA Chips

29. Technology Discussion—SNPs (“Snips”)

30. Technology Discussion—Synthetic Biology

31. Technology Discussion—Recombinant DNA

32. Technology Discussion—Polymerase Chain Reaction (PCR)

Plunkett Research Provides In-Depth Tables for the Following Biotech, Pharmaceuticals & Genetics Industry Statistics

1. Biotech IndustryStatistics and Market Size Overview

2. The U.S. Drug Discovery & Approval Process

3. U.S. FDA Novel New Drug Approvals by Year 2015-2024

4. Employment in Life & Physical Science Occupations by Business Type, U.S.: May 2024

5. Federal R&D & R&D Funding for Basic Research, U.S.: Fiscal Years 2023-2025

6. U.S. Exports & Imports of Pharmaceutical Products: 2019-2024

7. Prescription Drug Expenditures & Annual Percent Change, U.S.: 2017-2033

8. NSF Budget by Appropriation (Dollars in Millions), Fiscal Years: 2023-2025

9. Research Funding for Biological Sciences, U.S. National Science Foundation: Fiscal Years 2024-2026

10. The Nation's Health Dollar: 2025 Where It Came From (Projected)

11. The Nation's Health Dollar: 2025 Where It Went (Estimated)